| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/21/2006 | US20060211645 Modulation of neurodegenerative diseases |
| 09/21/2006 | US20060211643 Polycations capable of forming complexes with nucleic acids |
| 09/21/2006 | US20060211641 Modulation of immunostimulatory properties of oligonucleotide-based compounds by utilizing modified immunostimulatory dinucleotides |
| 09/21/2006 | US20060211639 Immunostimulatory nucleic acids and cancer medicament combination therapy for the treatment of cancer |
| 09/21/2006 | US20060211638 Exon 1 ss of pdgf alpha gene and utilization thereof |
| 09/21/2006 | US20060211637 Methods of down regulating target gene expression in vivo by introduction of interfering rna |
| 09/21/2006 | US20060211636 Macrolide Antibiotics |
| 09/21/2006 | US20060211635 total pomegranate tannins (TPT) including punicalagin; nutraceutical for cardiovascular health |
| 09/21/2006 | US20060211634 Antibiotic resistance |
| 09/21/2006 | US20060211633 D-mannose contraceptives |
| 09/21/2006 | US20060211632 PXR agonists for cardiovascular disease |
| 09/21/2006 | US20060211631 Transfusion preparation for peripheral intravenous administration and method of stabilizing vitamin b1 |
| 09/21/2006 | US20060211628 Treatment of multiple sclerosis with brain targeted anti oxidant compounds |
| 09/21/2006 | US20060211624 Methods and compositions for the treatment of parkinson's disease and other alpha-synucleinopathies |
| 09/21/2006 | US20060211617 Methods, compositions and articles of manufacture for contributing to the treatment of solid tumors |
| 09/21/2006 | US20060211613 Administering parathyroid hormone and bone resorption inhibitor; bone disorders |
| 09/21/2006 | US20060211611 Therapies and compositions for controlling the stress mechanism and for stabilizing hemostasis in an organism |
| 09/21/2006 | US20060211602 Use of alanyl aminopeptidase inhibitors and pharmaceutical compositions containing said inhibitors |
| 09/21/2006 | US20060211599 Reversibly heat-gelable aqueous composition |
| 09/21/2006 | US20060211114 Modulation of hedgehog-mediated signaling pathway |
| 09/21/2006 | US20060211058 Diagnosis and treatment of malignant neoplasms |
| 09/21/2006 | US20060211042 Methods of identifying modulators of cellular glycosylation using gtrap3-18 |
| 09/21/2006 | US20060211025 Molecular signatures of commonly fatal carcinomas |
| 09/21/2006 | US20060211013 Method for sorting antifungal molecules acting on the glucanosyltransferase activity |
| 09/21/2006 | US20060210974 Compositions and methods for preventing, treating and diagnosing diabetes |
| 09/21/2006 | US20060210660 Process for preparing an extract from ivy leaves |
| 09/21/2006 | US20060210659 Anti-obesity agent |
| 09/21/2006 | US20060210657 Compositions and methods for prostate and kidney health and disorders, an herbal preparation |
| 09/21/2006 | US20060210656 Synergistic Effects of Nuclear Transcription Factor NF-kB Inhibitors and Anti-Neoplastic Agents |
| 09/21/2006 | US20060210653 Compositions and methods for increasing metabolism, thermogenesis and/or muscular definition |
| 09/21/2006 | US20060210651 Methods and compositions involving aldose reductase |
| 09/21/2006 | US20060210650 Supplemental dietary composition for promoting weight loss |
| 09/21/2006 | US20060210648 Method for treating an inflammation or lesion caused by a virus |
| 09/21/2006 | US20060210647 Copper-dependent non-traditional pro-inflammatory cytokine export and methods, compositions and kits relating thereto |
| 09/21/2006 | US20060210646 Accelerator for mineral absorption and use thereof |
| 09/21/2006 | US20060210645 Pharmaceutically acceptable carrier for ophthalmic compositions |
| 09/21/2006 | US20060210640 Process for producing nanoparticles by spray drying |
| 09/21/2006 | US20060210639 Nanoparticulate bisphosphonate compositions |
| 09/21/2006 | US20060210638 Injectable compositions of nanoparticulate immunosuppressive compounds |
| 09/21/2006 | US20060210637 Stable tablet dosage forms of proton pump inhibitors |
| 09/21/2006 | US20060210632 Sublingual coated tablet of fentanyl |
| 09/21/2006 | US20060210630 Controlled release compositions of gamma-hydroxybutyrate |
| 09/21/2006 | US20060210628 Use of epinine for enhancing physical performance |
| 09/21/2006 | US20060210625 Sustained release of positively charged pharmacologically active molecules from a matrix containing polymers with polarized oxygen atoms |
| 09/21/2006 | US20060210624 Combination product comprising an antagonist or inverse agonist of histamine receptor h<sb>3 </sb>and an antipsychotic and antidepressant agent, and use thereof for the preparation of a medicament that prevents the adverse effects of psychotropic drugs |
| 09/21/2006 | US20060210622 Surface modified particulate compositions of biologically active substances |
| 09/21/2006 | US20060210621 consisting of partially hydrolyzed fucoidan, plum concentrate, grape concentrate, black currant concentrate, blueberry concentrate, raspberry concentrate, black pepper extract, Sichuan pepper extract, minerals, flavoring agent, and sweetener |
| 09/21/2006 | US20060210620 Co-precipitated amorphous losartan and dosage forms comprising the same |
| 09/21/2006 | US20060210619 Limposomes containing asiaticoside and the uses thereof |
| 09/21/2006 | US20060210618 Polyglycrine based phospholipid containing amide groups; surfactant, solubilizer, dispersant for cosmetics, lipid membrane for drug delivery systems |
| 09/21/2006 | US20060210617 Selected solvent is one that can substantially or fully solvate or dissolve the adhesive while keeping the fentanyl suspended in the solvated adhesive; provides non-invasive sustained analgesia for periods ranging from 24 hours to 168 hours |
| 09/21/2006 | US20060210615 Dermal or transdermal therapeutic system comprising an ormocer with barrier effect on a cover foil |
| 09/21/2006 | US20060210614 Method of treatment of a metabolic disease using intranasal administration of exendin peptide |
| 09/21/2006 | US20060210613 Therapeutic wound care product |
| 09/21/2006 | US20060210609 Fucoidan compositions and methods for dietary and nutritional supplements |
| 09/21/2006 | US20060210607 plant extracts from soybean, extracted in the presence of cyclodextrin ; enzymatically-modified isoflavones; easy adsorbed by the body, kept therein at a high concentration for a long time; increase the bone density and prevent osteoporosis; beverages, cosmetics, pharmaceuticals, or feeds; |
| 09/21/2006 | US20060210606 Food for improving clinical conditions capable of lowering the concentration of low-molecular weight nitrogen-containing compounds in blood |
| 09/21/2006 | US20060210593 Methods of making and methods of using antiseptic disinfectant, cosmetic and toiletries, medicine or food containing the same |
| 09/21/2006 | US20060210592 Use of rifaximin for the prevention of aspiration pneumonia and/or sepsis |
| 09/21/2006 | US20060210571 Engineering antibodies that bind irreversibly |
| 09/21/2006 | US20060210568 Methods and compositions for cancer treatment |
| 09/21/2006 | US20060210565 Antagonists of HMG1 for treating inflammatory conditions |
| 09/21/2006 | US20060210561 Dosages for treatment with anti-EGFR antibodies |
| 09/21/2006 | US20060210557 Stabilized liquid polypeptide formulations |
| 09/21/2006 | US20060210555 Compositions comprising immunoreactive reagents and saponins, and methods of use thereof |
| 09/21/2006 | US20060210553 Topical use of tyrosine kinase inhibitors of microbial origin to prevent and treat skin disorders characterised by excesssive cell proliferation |
| 09/21/2006 | US20060210552 Compositions and methods for systemic inhibition of cartilage degradation |
| 09/21/2006 | US20060210551 Use of a mast cell activation or degranulation blocking agent in the manufacture of a medicament for the treatment of a patient subjected to thrombolyses |
| 09/21/2006 | US20060210548 Method for reducing obstructive hydrocephalus |
| 09/21/2006 | US20060210546 Athlete dietary supplement |
| 09/21/2006 | US20060210533 Compounds and compositions for delivering active agents |
| 09/21/2006 | US20060210532 Means and methods for the recruitment and identification of stem cells |
| 09/21/2006 | US20060210530 Polymer coating of cells |
| 09/21/2006 | US20060210529 Method of attenuating neurogenic bruise formation |
| 09/21/2006 | US20060210528 Therapy for tropical diseases |
| 09/21/2006 | US20060210527 Cyclodextrin-based polymers for therapeutics delivery |
| 09/21/2006 | US20060210526 polyoxyethylene glycol-protein conjugate linked via linking group |
| 09/21/2006 | US20060210525 Dispersions |
| 09/21/2006 | US20060210516 Article with skin protecting and moisturizing compound |
| 09/21/2006 | US20060210515 Hair growth formula |
| 09/21/2006 | US20060210514 Skin protection and moisturizing compositions and method of making the same |
| 09/21/2006 | US20060210504 Compositions and methods for inhibiting eccrine perspiration in humans |
| 09/21/2006 | US20060210492 Use of rifaximin for treatment and prevention of periodontal conditions |
| 09/21/2006 | US20060210485 Pharmaceutical formulations |
| 09/21/2006 | US20060210484 Transmucosal absorption through oral mucosa to systemic circulatory system; bioavailability, rapid onset; active ingredient, solvent and low molecular weight hydrocarbon propellant |
| 09/21/2006 | US20060210483 Non-systemic antibiotic formulations and related method of use and treatment of upper respiratory infections |
| 09/21/2006 | US20060210482 Chemical composition and method for cold and sinus relief |
| 09/21/2006 | US20060210480 Treatment of reduction of dysphagia |
| 09/21/2006 | US20060210479 Targeting chelants and chelates |
| 09/21/2006 | US20060210477 Therapeutic agent for cancer |
| 09/21/2006 | US20060210475 Humanized L243 antibodies |
| 09/21/2006 | DE4404086B4 Pharmazeutische und/oder kosmetische Zusammensetzung Pharmaceutical and / or cosmetic composition |
| 09/21/2006 | DE4404085B4 Pharmazeutische und/oder kosmetische Zusammensetzung Pharmaceutical and / or cosmetic composition |
| 09/21/2006 | DE202006009610U1 Chitin, beta 1,3/1,6 D glucan and melanin bio spray, useful for fighting against foot fungus and simultaneous recovery of affected areas, comprises chitin, beta 1,3/1,6 D glucan and melanin complex, where the bio spray is a dry spray |
| 09/21/2006 | DE19681478B4 R-(-)-(E)-[4-(2,4-Dichlorphenyl)-1,3-dithiolan-2-yliden]-1-imidazolylacetonitril,Verfahren zu seiner Herstellung und seine Verwendung R - (-) - (E) - [4- (2,4-dichlorophenyl) -1,3-dithiolan-2-ylidene] -1-imidazolylacetonitril, process for its preparation and its use |
| 09/21/2006 | DE102006011111A1 Formulation for analgesic ear drops contains polyhydric alcohol, especially butan-1,3-diol or glycerol, dimethyl sulfoxide and optionally acid or buffer system and dexpanthenol |
| 09/21/2006 | DE102005012875A1 Verwendung von Amino substituierten 8-N-Benzimidazolen Use of amino-substituted 8-N-benzimidazoles |
| 09/21/2006 | DE102005012874A1 Amid substituierte 8-N-Benzimidazole, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel Amide substituted 8-N-benzimidazoles, process for their preparation and their use as medicaments |
| 09/21/2006 | DE102005012831A1 Herstellung eines Arzneimittels zur Senkung des Risikofaktors der Artherosklerose und/oder Erhöhung der Insulinsensitivität Manufacture of a medicament for reducing the risk factor of atherosclerosis and / or increasing insulin sensitivity |
| 09/21/2006 | DE102005012681A1 New 1,5-dihydro-pyrrol-2-one compounds are HDM2 inhibitors, useful for treating e.g. stroke, heart infarct, ischemia, multiple sclerosis, Alzheimer's disease, degenerative disease, viral infection and cancer |